Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.93 billion. The enterprise value is $1.27 billion.
Important Dates
The last earnings date was Thursday, February 5, 2026, before market open.
| Earnings Date | Feb 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 217.69 million shares outstanding. The number of shares has increased by 18.31% in one year.
| Current Share Class | 217.69M |
| Shares Outstanding | 217.69M |
| Shares Change (YoY) | +18.31% |
| Shares Change (QoQ) | +21.21% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 86.03% |
| Float | 202.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 32.01 |
| Forward PS | 32.11 |
| PB Ratio | 2.93 |
| P/TBV Ratio | 2.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 24.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.39, with a Debt / Equity ratio of 0.12.
| Current Ratio | 15.39 |
| Quick Ratio | 15.11 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -22.82 |
Financial Efficiency
Return on equity (ROE) is -54.85% and return on invested capital (ROIC) is -30.07%.
| Return on Equity (ROE) | -54.85% |
| Return on Assets (ROA) | -26.66% |
| Return on Invested Capital (ROIC) | -30.07% |
| Return on Capital Employed (ROCE) | -35.66% |
| Weighted Average Cost of Capital (WACC) | 9.32% |
| Revenue Per Employee | $159,849 |
| Profits Per Employee | -$818,274 |
| Employee Count | 325 |
| Asset Turnover | 0.08 |
| Inventory Turnover | 61.68 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.12% in the last 52 weeks. The beta is 0.90, so OCUL's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +19.12% |
| 50-Day Moving Average | 11.55 |
| 200-Day Moving Average | 10.96 |
| Relative Strength Index (RSI) | 34.92 |
| Average Volume (20 Days) | 4,601,137 |
Short Selling Information
The latest short interest is 11.51 million, so 5.29% of the outstanding shares have been sold short.
| Short Interest | 11.51M |
| Short Previous Month | 12.79M |
| Short % of Shares Out | 5.29% |
| Short % of Float | 5.68% |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, OCUL had revenue of $51.95 million and -$265.94 million in losses. Loss per share was -$1.42.
| Revenue | 51.95M |
| Gross Profit | -151.72M |
| Operating Income | -270.02M |
| Pretax Income | -265.94M |
| Net Income | -265.94M |
| EBITDA | -265.69M |
| EBIT | -270.02M |
| Loss Per Share | -$1.42 |
Full Income StatementBalance Sheet
The company has $737.06 million in cash and $76.97 million in debt, with a net cash position of $660.09 million or $3.03 per share.
| Cash & Cash Equivalents | 737.06M |
| Total Debt | 76.97M |
| Net Cash | 660.09M |
| Net Cash Per Share | $3.03 |
| Equity (Book Value) | 654.31M |
| Book Value Per Share | 3.03 |
| Working Capital | 731.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$204.88 million and capital expenditures -$12.01 million, giving a free cash flow of -$216.89 million.
| Operating Cash Flow | -204.88M |
| Capital Expenditures | -12.01M |
| Free Cash Flow | -216.89M |
| FCF Per Share | -$1.00 |
Full Cash Flow StatementMargins
| Gross Margin | -292.04% |
| Operating Margin | -519.75% |
| Pretax Margin | -511.90% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.31% |
| Shareholder Yield | -18.31% |
| Earnings Yield | -13.76% |
| FCF Yield | -11.22% |
Analyst Forecast
The average price target for OCUL is $22.56, which is 154.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.56 |
| Price Target Difference | 154.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 79.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 4.99 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.99 |
| Piotroski F-Score | 2 |
